Fiche centre
Texas Children's Hospital
Houston — United States
Essais liés9clinical trials
VilleHoustonlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04288726
Essais cliniques associés
9| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Eteplirsen | Myopathies | À vérifier | NCT06606340 | EVOLVE — A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice | ENROLLING_BY_INVITATION |
| Biospecimen Collection | Cancer | Phase 1/2 | NCT01089101 | Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma | ACTIVE_NOT_RECRUITING |
| EXCOR Active Driving System for Pediatric VAD | Insuffisance cardiaque | Non applicable | NCT05610787 | EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study | ENROLLING_BY_INVITATION |
| Ataluren | Myopathies | Phase 3 | NCT01247207 | Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) | TERMINATED |
| CD30.CAR-EBVST cells | Cancer | Phase 1 | NCT04288726 | Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas | ACTIVE_NOT_RECRUITING |
| Obecabtagene autoleucel | Lupus | Phase 2 | NCT07053800 | LUMINA — Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN) | RECRUITING |
| zorevunersen | Épilepsie | Phase 3 | NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | ACTIVE_NOT_RECRUITING |
| Casimersen | Myopathies | Phase 3 | NCT03532542 | An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy | TERMINATED |
| baclofen | Myopathies | Phase 1 | NCT00607542 | Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity | COMPLETED |